Top Verdicts
Feb. 16, 2012
Top Defense Verdicts--GlaxoSmithKline v. Abbott Laboratories
The resulting $3.5 million verdict in March was seen as a victory considering the much larger amount that plaintiff GlaxoSmithKline sought in return for lost profits from reduced sales of its HIV drug Lexiva.
Glaxo originally sought $571 million ...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In